| Jul 8 |
Hookipa Pharma to execute 1-for-10 reverse stock split
|
| Jul 8 |
HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
|
| Jul 2 |
HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
|
| Jul 1 |
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
|
| Jun 5 |
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
| Jun 4 |
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
|
| May 30 |
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
|
| May 24 |
HOOKIPA stock falls 20% in wake of Phase 1/2 study results
|
